BRO BEHIND BARS
for years “pharma Bro” martin shkreli has courted trouble—so much so that our february 2016 feature on the drug exec was headlined “solving pharma’s shkreli problem.” matthew Herper detailed how shkreli, then just 32, had become “the most hated man in america” by hiking the cost of an infectionfighting medicine by 5,000% and doing so with icy hauteur. “i think health care prices are inelastic,” he told Herper at a Forbes health care conference, later adding that “my investors know what i do with [their] money. i multiply it for them. That’s my job. i did really well, and i’m going to keep doing it.” Well, for a time. on march 9, shkreli was sentenced to seven years in prison—not for the price hikes, which were unseemly but legal, but for securities fraud regarding his hedge fund, exaggerating to investors his actual assets under management ($1 million) by a factor of 125. The government can now seize assets to satisfy a concomitant $7.36 million forfeiture. pharma Bro—for the next handful of years, anyway—has ceded the spotlight to prison Bro.